The changed levels and expression of BDNF have been described in the brain and blood of AD patients [226–229], and hypermethylation of the BDNF promoter region, a new approach to evaluate the relationship between BDNF and AD, has been found in postmortem AD brain samples and peripheral blood cells of subjects with AD [230, 231]. The gene discussed is BDNF; the disease is Alzheimer disease.